Johnson & Johnson: Osteoarthritis, Hip trials

The registry lists 12 Osteoarthritis, Hip studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 2 1Phase 3 9No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The MONOVISC Hip Osteoarthritis StudyTerminatedNCT02698865Phase 3Results posted
• Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee ReplacementCompletedNCT01094886Phase 3Results posted
• Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the KneeCompletedNCT00980798Phase 3Results posted
• A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic PainCompletedNCT00361504Phase 3Results posted
• Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip ReplacementCompletedNCT02096198
• Observational Study Investigating the Effectiveness of Fentanyl Matrix in Relieving Pain and Improving Function in Patients With Osteoarthritis of the Knee or HipCompletedNCT01119885
• A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related PainTerminatedNCT00973141Phase 2
• A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With OsteoarthritisCompletedNCT00411164Phase 3
• An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)CompletedNCT00399048Phase 3
• An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.CompletedNCT00240799Phase 3
• An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or KneeCompletedNCT00240786Phase 3
• A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or KneeCompletedNCT00240773Phase 3